Personalis Price to Book Ratio 2018-2023 | PSNL
Historical price to book ratio values for Personalis (PSNL) over the last 10 years. The current price to book ratio for Personalis as of May 03, 2024 is 0.61.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Personalis Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-05-03 |
1.54 |
|
0.60 |
| 2023-12-31 |
2.10 |
$2.56 |
0.82 |
| 2023-09-30 |
1.21 |
$3.09 |
0.39 |
| 2023-03-31 |
2.76 |
$4.14 |
0.67 |
| 2022-12-31 |
1.98 |
$4.67 |
0.42 |
| 2022-09-30 |
2.97 |
$5.27 |
0.56 |
| 2022-06-30 |
3.45 |
$5.77 |
0.60 |
| 2022-03-31 |
8.19 |
$6.34 |
1.29 |
| 2021-12-31 |
14.27 |
$6.91 |
2.07 |
| 2021-03-31 |
24.61 |
$7.96 |
3.09 |
| 2020-12-31 |
36.61 |
$4.99 |
7.34 |
| 2020-09-30 |
21.67 |
$5.25 |
4.13 |
| 2020-06-30 |
12.97 |
$2.92 |
4.44 |
| 2020-03-31 |
8.07 |
$3.15 |
2.56 |
| 2019-12-31 |
10.90 |
$3.41 |
3.19 |
| 2019-06-30 |
27.15 |
$3.76 |
7.22 |
| 2023-06-30 |
1.88 |
$3.63 |
0.52 |
| 2021-09-30 |
19.24 |
$7.28 |
2.64 |
| 2021-06-30 |
25.30 |
$7.66 |
3.30 |
| 2019-09-30 |
14.68 |
$3.58 |
4.10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.081B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
